• 1
    Sadikot, R. T., Blackwell, T. S., Christman, J. W. and Prince, A. S., Pathogen-host interactions in Pseudomonas aeruginosa pneumonia: The state of the art. Am. J. Respir. Crit. Care Med. 2005. 171: 12091223.
  • 2
    Chastre, J. and Fragon, J. -Y., Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2002. 165: 867903.
  • 3
    Simmons, D. L., Botting, R. M. and Hla, T., Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004. 56: 387437.
  • 4
    Funk, C. D., Prostaglandins and leukotrienes: Advances in eicosonoid biology. Science 2001. 294: 18711875.
  • 5
    Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P. and Versteeg, H. H., Prostanoids and prostanoid receptors in signal transduction. Int. J. Biochem. Cell Biol. 2004. 36: 11871205.
  • 6
    Gauthier, A., Thomas, N. A. and Finlay, B. B., Bacterial injection machines. J. Biol. Chem. 2003. 278: 2527325276.
  • 7
    Galan, J. E. and Collmer, A., Type III secretion machines: Bacterial devices for protein delivery into host cells. Science 1999. 284: 13221328.
  • 8
    Hauser, A. R. and Engel, J. N., Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells. Infect. Immun. 1999. 67: 55305537.
  • 9
    Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R. and Wiener-Kronish, J. P., Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 1999. 104: 743750.
  • 10
    Shime, N., Sawa, T., Fujimoto, J., Faure, K., Allmond, L. R., Karaca, T., Swanson, B. L. et al., Therapeutic administration of Anti-PcrV F(ab)2 in sepsis associated with Pseudomonas aeruginosa. J. Immunol. 2001. 167: 58805886.
  • 11
    Hauser, A. R., Cobb, E., Bodi, M., Mariscal, D., Valles, J., Engel, J. N. and Rello, J., Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 2002. 3: 521528.
  • 12
    Smith, R. S., Harris, S. G., Phipps, R. and Iglewski, B., The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo. J. Bacteriol. 2002. 184: 11321139.
  • 13
    Sadikot, R. T., Zeng, H., Yull, F. E., Li, B., Cheng, D. S., Kernodle, D. S., Jansen, E. D. et al., p47phox deficiency impairs NF-kappa B activation and host defense in P. aeruginosa pneumonia. J. Immunol. 2004. 172: 18011808.
  • 14
    Mancuso, P., Standiford, T., Marshall, J. T. and Peters-Golden, M., 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 1998. 66: 51405146.
  • 15
    Davidson, J., Kerr, A., Guy, K. and Rotondo, D., Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cells. Immunology 1998. 94: 228234.
  • 16
    Aronoff, D. M., Canetti, C. and Peters-Golden, M., Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 2004. 173: 559565.
  • 17
    Chen, N. and Reis, C. S., Distinct roles of eicosanoids in the immune response to viral encephalitis: or why you should take NSAIDS. Viral Immunol. 2002. 15: 133146.
  • 18
    Chen, Y., Zhang, J., Moore, S. A., Ballas, Z. K., Portanova, J. P., Krieg, A. M. and Berg, D. J., CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int. Immunol. 2001. 13: 10131016.
  • 19
    Bowman, C. C. and Bost, K. L., Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J. Immunol. 2004. 172: 24692475.
  • 20
    Deva, R., Shankaranarayanan, P., Ciccoli, R. and Nigam, S., Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: Pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B. J. Immunol. 2003. 171: 30473055.
  • 21
    Yoneda, H., Miura, K., Matsushima, H., Sugi, K., Murakami, T., Ouchi, K., Yamashita, K. et al., Aspirin inhibits Chlamydia pneumoniae-induced NF-kappa B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth. J. Med. Microbiol. 2003. 52: 409415.
  • 22
    Juttner, S., Cramer, T., Wessler, S., Walduck, A., Gao, F., Schmitz, F., Wunder, C. et al., Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: Critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors. Cell. Microbiol. 2003. 5: 821834.
  • 23
    Gessell-Lee, D. L., Popov, V. L., Boldogh, I., Olano, J. P. and Peterson, J. W., Role of cyclooxygenase enzymes in a murine model of experimental cholera. Infect. Immun. 2003. 71: 62346242.
  • 24
    Konstan, M. W., Vargo, K. M. and Davis, P. B., Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. Am. Rev. Respir. Dis. 1990. 141: 186192.
  • 25
    Mancuso, P., McNish, R. W., Peters-Golden, M. and Brock, T. G., Evaluation of phagocytosis and arachidonate metabolism by alveolar macrophages and recruited neutrophils from F344×BN rats of different ages. Mech. Ageing Dev. 2001. 122: 18991913.
  • 26
    Armstrong, R. A., Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol. 1995. 116: 29032905.
  • 27
    Chen, N., Restivo, A. and Reiss, C. S., Selective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. Prostaglandins Other Lipid Mediat. 2002. 67: 14355.
  • 28
    Hata, A. N. and Breyer, R. M., Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation. Pharmacol. Ther. 2004. 103: 147166
  • 29
    Olson, J. C., Fraylick, J. E., McGuffie, E. M., Dolan, K. M., Yahr, T. L., Frank, D. W. and Vincent, T. S., Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 1999. 67: 28472854.
  • 30
    Sundin, C., Hallberg, B. and Forsberg, A., ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo. FEMS Microbiol. Lett. 2004. 234: 8791.
  • 31
    Coburn, J. and Frank, D. W., Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 1999. 67: 31513154.
  • 32
    Rabin, S. D. and Hauser, A. R., Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect. Immun. 2005. 73: 573582.
  • 33
    Sato, H. and Frank, D. W., ExoU is a potent intracellular phospholipase. Mol. Microbiol. 2004. 53: 12791290.
  • 34
    Phillips, R. M., Six, D. A., Dennis, E. A. and Ghosh, P., In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 2003. 278: 4132641332.
  • 35
    Saliba, A. M., Nascimento, D. O., Silva, M. C., Assis, M. C., Gayer, C. R., Raymond, B., Coelho, M. G. et al., Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell. Microbiol. 2005. 7: 18111822.
  • 36
    Ha, U. H., Wang, Y. and Jin, S., DsbA of Pseudomonas aeruginosa is essential for multiple virulence factors. Infect. Immun. 2003. 71: 15901595.
  • 37
    Sadikot, R. T., Jansen, E. D., Blackwell, T. R., Zoia, O., Yull, F., Christman, J. W. and Blackwell, T. S., High-dose dexamethasone accentuates nuclear factor-kappa B activation in endotoxin-treated mice. Am. J. Respir. Crit. Care Med. 2001. 164: 873878.
  • 38
    Matsumoto, H., Ma, W. G., Daikoku, T., Zhao, X., Paria, B. C., Das, S. K., Trzaskos, J. M. and Dey, S. K., Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J. Biol. Chem. 2002. 277: 2926029267.
  • 39
    Kennedy, C. R., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A. et al., Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat. Med. 1999. 5: 217220.